ENDRA Life Sciences Inc. Common Stock
NDRA Real Time Price USDRecent trades of NDRA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in NDRA holdings by institutional investors
Quarterly net insider trading by NDRA's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
NDRA Estimated quarterly lobbying spending
NDRA Revenue by Segment or Geography
New NDRA patent grants
-
Patent Title: Radio frequency applicator Jul. 08, 2025
-
Patent Title: Thermoacoustic measurement probe Dec. 19, 2023
-
Patent Title: Radio frequency applicator for a thermoacoustic imaging system Aug. 22, 2023
-
Patent Title: Thermoacoustic measurement probe Apr. 04, 2023
-
Patent Title: Methods and systems for exchange of equipment performance data Feb. 07, 2023
-
Patent Title: Methods and systems for exchange of equipment performance data Feb. 07, 2023
-
Patent Title: System for monitoring tissue temperature Oct. 25, 2022
-
Patent Title: Method for manufacturing a radio frequency applicator Sep. 27, 2022
-
Patent Title: Methods and systems for exchange of equipment performance data Aug. 02, 2022
-
Patent Title: Methods and systems for exchange of equipment performance data Jul. 19, 2022
-
Patent Title: Methods and systems for exchange of equipment performance data Jul. 05, 2022
-
Patent Title: Broadband applicator for thermoacoustic signal generation Jun. 28, 2022
-
Patent Title: Acoustically compatible radio-frequency applicator method and system May. 24, 2022
-
Patent Title: Methods and systems for exchange of equipment performance data Apr. 26, 2022
-
Patent Title: Method and system for enhancing rf energy delivery during thermoacoustic imaging Apr. 19, 2022
-
Patent Title: Method and system for determining a material type of an object of interest Mar. 08, 2022
-
Patent Title: Tissue-mimicking material for a multi-modality imaging phantom Nov. 16, 2021
-
Patent Title: Thermoacoustic transducer with integrated switch Nov. 16, 2021
-
Patent Title: Method and system for monitoring tissue temperature Oct. 12, 2021
-
Patent Title: Method and system for determining a parameter of a material of interest Jul. 20, 2021
-
Patent Title: Thermal ablation system and method with integrated thermoacoustic temperature measurement Jul. 06, 2021
-
Patent Title: Method and system for estimating fractional fat content of an object of interest Jul. 06, 2021
-
Patent Title: Method and system for determining at least one parameter of interest of a material Jun. 29, 2021
-
Patent Title: Acoustically isolated thermoacoustic imaging probe and process of manufacture May. 04, 2021
-
Patent Title: Systems and methods for thermoacoustic transducer optimization May. 04, 2021
-
Patent Title: Systems and methods for imaging biological tissue structures Jan. 26, 2021
-
Patent Title: Shielded ultrasound transducer and imaging system employing the same Jan. 12, 2021
-
Patent Title: Method and system for reconstructing a thermoacoustic image Jun. 23, 2020
-
Patent Title: Radio frequency applicator and thermoacoustic imaging system employing the same Jun. 16, 2020
-
Patent Title: Thermoacoustic imaging probe with outdents May. 05, 2020
-
Patent Title: Thermoacoustic imaging probe May. 05, 2020
-
Patent Title: Method and system for determining fractional fat content of tissue Apr. 16, 2019
-
Patent Title: Systems and methods for imaging biological tissue structures Jul. 24, 2018
-
Patent Title: Method and system for correcting fat-induced aberrations Jul. 17, 2018
-
Patent Title: System for estimating fractional fat content of an object May. 29, 2018
-
Patent Title: Method and system for estimating fractional fat content of an object Feb. 13, 2018
-
Patent Title: Method and system for estimating fractional fat content of an object Feb. 13, 2018
Federal grants, loans, and purchases
Estimated quarterly amount awarded to NDRA from public contracts
Recent insights relating to NDRA
Recent picks made for NDRA stock on CNBC
ETFs with the largest estimated holdings in NDRA
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NDRA stock a Buy, Sell, or Hold?
- What is the price target for $NDRA stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NDRA stock?
- Who owns the most shares of $NDRA stock?
- What funds own $NDRA stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NDRA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
- Address Ann Arbor, MI
- Market Cap 5.0 million
- Employees 16
- Industrial Classification Electromedical & Electrotherapeutic Apparatus